HSX: Prosthesis, Knee, Femorotibial, Non-Constrained, Cemented, Metal/Polymer
What it covers
A knee joint femorotibial metal/polymer non-constrained cemented prosthesis is a device intended to be implanted to replace part of a knee joint. The device limits minimally (less than normal anatomic constraints) translation in one or more planes. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral condylar resurfacing component or components made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components made of ultra-high molecular weight polyethylene and are intended for use with bone cement (§ 888.3027).
The identification in 21 CFR 888.3520, knee joint femorotibial metal/polymer non-constrained cemented prosthesis. FDA gives HSX no definition of its own, so the regulation’s describes it.
FDA flags HSX devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261609 | Freedom Partial Knee System | Maxx Orthopedics, Inc. | Aug 4, 2026 | Traditional |
| K260796 | Tahoe Unicondylar Knee System with TiNbN Overcoat | Shalby Advanced Technologies, Inc. Dba Consensus Orthopedics | Apr 2, 2026 | Special |
| K251771 | Cambridge Partial Knee | Signature Orthopaedics Pty, Ltd. | Dec 16, 2025 | Traditional |
| K251834 | Persona Partial Knee | Zimmer Biomet | Aug 15, 2025 | Traditional |
| K251618 | MOTO Partial Knee System Extension | Medacta International S.A. | Jul 24, 2025 | Traditional |
| K251453 | Arthrex iBalance Partial Knee System | Arthrex, Inc. | Jul 1, 2025 | Traditional |
| K241260 | ACTIFY Unicondylar Knee System | Globus Medical, Inc. | Dec 6, 2024 | Traditional |
| K242711 | JOURNEY II Unicompartmental Knee System (JOURNEY II UK) | Smith & Nephew, Inc. | Oct 30, 2024 | Traditional |
| K242746 | OvertureTi Knee Resurfacing SystemTM | Overture Orthopaedics | Oct 7, 2024 | Special |
| K232114 | TRIBRID® Unicompartmental Knee System | Kyocera Medical Technologies, Inc. | Apr 4, 2024 | Traditional |
Clearances by year
50 HSX 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 2 | 52 |
| 2025 | 4 | 59 |
| 2024 | 4 | 133 |
| 2023 | 1 | 310 |
| 2022 | 2 | 172 |
| 2021 | 7 | 81 |
| 2020 | 4 | 40 |
| 2019 | 7 | 90 |
| 2018 | 2 | 140 |
| 2017 | 5 | 160 |
| 2016 | 3 | 147 |
| 2015 | 1 | 72 |
| 2013 | 2 | 158 |
| 2012 | 5 | 88 |
| 2011 | 1 | 85 |
Who submits
24 applicants cleared a HSX device since 2011. 60% of the clearances went to applicants in United States, then Canada (14%), Switzerland (10%) and Belgium (8%). By type: Traditional 84%, Special 14% and Abbreviated 2%.
| Applicant | Clearances since 2011 |
|---|---|
| Bodycad Laboratories, Inc. | 7 |
| Smith & Nephew, Inc. | 7 |
| Medacta International S.A. | 5 |
| Materialise NV | 4 |
| Arthrex, Inc. | 3 |
| Conformis, Inc. | 3 |
| Howmedica Osteonics Corp. A.K.A. Stryker Orthopaedics | 2 |
| Signature Orthopaedics Pty, Ltd. | 2 |
How FDA classifies it
Class II.
From 21 CFR 888.3520.
Standards
21 CFR 888.3520 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent HSX clearances declared.
Ask about HSX
Questions about HSX
What is FDA product code HSX?
Product code HSX, “Prosthesis, Knee, Femorotibial, Non-Constrained, Cemented, Metal/Polymer” in FDA's classification database, is a Class II device type under 21 CFR 888.3520 (knee joint femorotibial metal/polymer non-constrained cemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 115 clearances under HSX, 50 of them since 2011.
How many 510(k) clearances are there under HSX?
FDA’s 510(k) database listed 115 clearances under HSX as of Oct 29, 2026, 50 of them decided since 2011; the most recent decision was Aug 4, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a HSX 510(k)?
For the 8 HSX clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 59 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most HSX clearances?
Since 2011: Bodycad Laboratories, Inc. (7), Smith & Nephew, Inc. (7), Medacta International S.A. (5), Materialise NV (4) and Arthrex, Inc. (3). 24 applicants have cleared a HSX device in that time.